Cargando…

Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia

The objective of this study was to compare systemic and local cytokine profiles and neutrophil responses in patients with severe versus non-severe community-acquired pneumonia (CAP). Hospitalized patients with CAP were grouped according to the pneumonia severity index (PSI), as non-severe (PSI < ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez-Botran, Rafael, Uriarte, Silvia M., Arnold, Forest W., Rodriguez-Hernandez, Lisandra, Rane, Madhavi J., Peyrani, Paula, Wiemken, Timothy, Kelley, Robert, Uppatla, Srinivas, Cavallazzi, Rodrigo, Blasi, Francesco, Morlacchi, Letizia, Aliberti, Stefano, Jonsson, Colleen, Ramirez, Julio A., Bordon, Jose
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087758/ https://www.ncbi.nlm.nih.gov/pubmed/24557760 http://dx.doi.org/10.1007/s10753-014-9840-2

Ejemplares similares

812 Macrolide Use and Innate Immunity Components in Hospitalized Patients with Community-Acquired Pneumonia
por: Arnold, Forest W., et al.
Publicado: (2014)

Serum and exhaled breath condensate inflammatory cytokines in community-acquired pneumonia: a prospective cohort study
por: Aliberti, Stefano, et al.
Publicado: (2016)

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States
por: Ramirez, Julio, et al.
Publicado: (2023)

The upper respiratory tract microbiome of hospitalised patients with community-acquired pneumonia of unknown aetiology: a pilot study
por: Wiemken, Timothy L., et al.
Publicado: (2015)

793 Incidence of Cardiovascular Events in Patients with Influenza Pneumonia or Pneumonia Due to Other Etiologies
por: Juan, Jorge Perez San, et al.
Publicado: (2014)

Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
por: Burk, Michael, et al.
Publicado: (2016)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia
por: Aliberti, Stefano, et al.
Publicado: (2015)

Insights into the Use of C-Reactive Protein as a Diagnostic Index of Disease Severity in COVID-19 Infections
por: Potempa, Lawrence A., et al.
Publicado: (2020)

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
por: Sheikh, Daniya, et al.
Publicado: (2022)

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Ali, Ahmed Shebl, et al.
Publicado: (2023)

Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis
por: Aliberti, Stefano, et al.
Publicado: (2014)

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

Simple and fast prediction of Legionella sp. in community-acquired pneumonia: validation of a prediction rule
por: Haubitz, S, et al.
Publicado: (2013)

Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007)

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study
por: Ramirez, Julio, et al.
Publicado: (2021)

Understanding why low-risk patients accept vaccines: a socio-behavioral approach
por: Wiemken, Timothy L., et al.
Publicado: (2015)

Phenotypic Differences in Virulence and Immune Response in Closely Related Clinical Isolates of Influenza A 2009 H1N1 Pandemic Viruses in Mice
por: Camp, Jeremy V., et al.
Publicado: (2013)

Real-time enrollment dashboard for multisite clinical trials
por: Mattingly, William A., et al.
Publicado: (2015)

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
por: Blasi, Francesco, et al.
Publicado: (2013)

Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia
por: Kim, Richard Y., et al.
Publicado: (2021)

Non-Intensive Care Unit Acquired Pneumonia: A New Clinical Entity?
por: Di Pasquale, Marta, et al.
Publicado: (2016)

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
por: Ramirez, Julio A., et al.
Publicado: (2020)

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design
por: McLaughlin, John M, et al.
Publicado: (2018)

Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
por: Ramirez, Julio A, et al.
Publicado: (2012)

Effectiveness of oseltamivir treatment on clinical failure in hospitalized patients with lower respiratory tract infection
por: Wiemken, Timothy L., et al.
Publicado: (2021)

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza
por: Spindel, Jeffrey, et al.
Publicado: (2023)

Idiopathic interstitial pneumonia in a patient with von Hippel–Lindau syndrome: a first case
por: Morlacchi, Letizia Corinna, et al.
Publicado: (2023)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
por: Bordon, Jose, et al.
Publicado: (2021)

Trends in Pneumonia Mortality Rates and Hospitalizations by Organism, United States, 2002–2011
por: Wuerth, Brandon A., et al.
Publicado: (2016)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Severe community-acquired meningitis
por: Boisson, Christophe, et al.
Publicado: (1999)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Severe Community-Acquired Pneumonia
por: Sligl, Wendy I., et al.
Publicado: (2013)

Severe community-acquired pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Association and predictive value of biomarkers with severe outcomes in hospitalized patients with SARS-CoV-2 infection
por: Fernandez-Botran, Rafael, et al.
Publicado: (2022)

Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection
por: Cosentini, Roberto, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6ktjktjd1lt407ptjm5qucl1l2